Gerresheimer acquires Sensile Medical

With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers. Sensile Medical develops innovative drug delivery products and platforms, including digital connected capabilities. It is already working highly successfully with customers on the development of devices for diabetics and patients with heart complaints.

Gerresheimer is a leading global partner to the pharma and healthcare industry focusing on specialty glass and plastic products. The company has worldwide operations and about 10,000 employees manufacture the products in local markets, close to the customers. With plants in Europe, North America, South America and Asia, Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

(Press release)